Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Silverstone

Showing results (131-140 of 133) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 133 results.
Frontiers in Psychiatry|August 29, 2025
Predictors of poor quality of life for patients discharged from acute psychiatric care in AlbertaErnest Owusu, Wanying Mao, Reham Shalaby, et al.
BMC Psychiatry|March 28, 2025
The prevalence and correlates of low resilience in patients prior to discharge from acute psychiatric units in Alberta, CanadaErnest Owusu, Wanying Mao, Reham Shalaby, et al.
Molecular Psychiatry|October 14, 2015
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trialL N Yatham, S Beaulieu, A Schaffer, et al.
Pageof 14

Showing results (131-140 of 133) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 133 results.
Frontiers in Psychiatry|August 29, 2025
Predictors of poor quality of life for patients discharged from acute psychiatric care in AlbertaErnest Owusu, Wanying Mao, Reham Shalaby, et al.
BMC Psychiatry|March 28, 2025
The prevalence and correlates of low resilience in patients prior to discharge from acute psychiatric units in Alberta, CanadaErnest Owusu, Wanying Mao, Reham Shalaby, et al.
Molecular Psychiatry|October 14, 2015
Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trialL N Yatham, S Beaulieu, A Schaffer, et al.
Pageof 14